Sort
39,280 grants matching “leukemia”
Function and Regulation of the ETS Transcriptional Repressor Tel-1/YAN
$339,223Ilaria Rebay · University Of Chicago · R01 · FY2014 · GM
Function and Regulation of the ETS Transcriptional Repressor Tel-1/YAN
$339,223Ilaria Rebay · University Of Chicago · R01 · FY2015 · GM
Transcriptional Repression by Polycomb Group Products
$339,217Jeffrey A Simon · University Of Minnesota · R01 · FY2014 · GM
Transcriptional Repression by Polycomb Group Products
$339,217Jeffrey A Simon · University Of Minnesota · R01 · FY2016 · GM
Transcriptional Repression by Polycomb Group Products
$339,217Jeffrey A Simon · University Of Minnesota · R01 · FY2017 · GM
Transcriptional Repression by Polycomb Group Products
$339,217Jeffrey A Simon · University Of Minnesota · R01 · FY2015 · GM
Assessment of Clinical Retinoid Activity in Leukemia
$339,202Montefiore Medical Center (Bronx, Ny) · R01 · FY2005 · CA
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
$339,156Rui Lu · University Of Alabama At Birmingham · R01 · FY2023 · CA
Role of Gab2 in Mast Cell Function and Ontogeny
$339,148Beth Israel Deaconess Medical Center · R01 · FY2004 · AI
Regenerative Therapies for Inherited Blood Disorders-Gene therapy
$339,113Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Investigation of the mechanisms of action of eltrombopag
$339,113Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Decision Models to Compare Treatments in Older Patients with AML
$339,101Martine Extermann · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity
$339,052Paul W. Burridge · Northwestern University At Chicago · R01 · FY2018 · CA
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity
$339,052Paul W. Burridge · Northwestern University At Chicago · R01 · FY2020 · CA
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity
$339,052Paul W. Burridge · Northwestern University At Chicago · R01 · FY2021 · CA
Mechanisms of selective excision and oxidative repair of alkylated DNA
$339,020Manel Camps · University Of California Santa Cruz · R01 · FY2012 · ES
Integration of epigenetic and non-coding RNA mechanism in leukemia
$339,008Sara E Meyer · Thomas Jefferson University · R37 · FY2024 · CA
The Biology of Mutant STAT6 in Follicular Lymphoma
$339,008Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Genomics of Familial MDS/AML
$338,993Timothy A Graubert · Washington University · P01 · FY2016 · CA
Validating and targeting USP35 for anticancer drug development
$338,984Changwei Liu · University Of Colorado Denver · U01 · FY2019 · CA
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
$338,967Yvette Y Yien · Boston Children'S Hospital · P01 · FY2020 · HL
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
$338,967Yvette Y Yien · Boston Children'S Hospital · P01 · FY2021 · HL
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
$338,967Yvette Y Yien · Boston Children'S Hospital · P01 · FY2019 · HL
Harnessing Alloreactivity
$338,949Fuchs Ephraim · Johns Hopkins University · P01 · FY2008 · CA
mTOR, Inflammation and Senescence of Hematopoietic Stem Cells
$338,919Pan Zheng · Children'S Research Institute · R01 · FY2014 · AG